1-6 of 6
Catherine Chatelanaz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Who Are the Type 2 Von Willebrand Disease Patients? Results from Interim Analysis of the French HRQoL Study: Wish-Qol .

Annie Borel-Derlon, MD PhD, Jenny Goudemand, MD PhD, Dominique Desprez, MD, Céline Falaise, Fabienne Genre Volot, MD, Laurent Ardillon, MD, Brigitte Pan-Petesch, MD, Catherine Chatelanaz, Catherine Doriat-Robin, Agnès Veyradier, Sr., MD PhD, Sylvia Von Mackensen
Journal: Blood
Blood (2018) 132 (Supplement 1): 2468.
https://doi.org/10.1182/blood-2018-99-113289
Published: 2018
Journal Articles

Gastrointestinal Bleeding and Angiodysplasia in Von Willebrand Disease: Results from the Ongoing French HRQoL Study: Wish-Qol

Annie Borel-Derlon, MD PhD, Dominique Desprez, MD, Fabienne Volot, MD, Herve Chambost, MD PhD, Sophie Bayard, MD, Catherine Chatelanaz, Catherine Doriat-Robin, Yves Gruel, MD PhD, Agnès Veyradier, Sr., MD PhD, Jenny Goudemand, MD PhD, Sylvia Von Mackensen, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4866.
https://doi.org/10.1182/blood.V130.Suppl_1.4866.4866
Published: 2017
Journal Articles

Wish-Qol Study - Assessment of Health-Related Quality of Life (HRQoL) and Health-Economic Aspects in Patients with Von Willebrand Disease (VWD) in France: Results of the Women Cohort

Annie Borel-Derlon, MD PhD, Jenny Goudemand, MD PhD, Dominique Desprez, MD, Fabienne Volot, MD, Yves Gruel, MD, Sophie Bayard, MD, Catherine Chatelanaz, Catherine Doriat-Robin, Agnes Veyradier, MD PhD, Edith Fressinaud, MD, Sylvia von Mackensen, PhD
Journal: Blood
Blood (2016) 128 (22): 1395.
https://doi.org/10.1182/blood.V128.22.1395.1395
Published: 2016
Journal Articles

Treatment of Von Willebrand Disease Women Undergoing Childbirth with a Von Willebrand Factor Product with a Low Content of Factor VIII: Results From 4 Multicenter Studies

Catherine Boyer-Neumann, Annie Borel-Derlon, MD, PhD, Jenny Goudemand, MD, PhD, Ségolène Claeyssens, Pierre-Marie Sie, MD, PhD, Philippe Moreau, Marie-Anne Bertrand, MD, Chantal Rothschild, MD, Benoît Guillet, MD, PhD, Jeanne Yvonne Borg, Catherine Chatelanaz, Wil Stevens, Françoise Bridey, Celine Henriet
Journal: Blood
Blood (2012) 120 (21): 3375.
https://doi.org/10.1182/blood.V120.21.3375.3375
Published: 2012
Journal Articles

Clinical Use of a Von Willebrand Factor with a Low FVIII Content in Von Willebrand Disease Patients Undergoing Surgical Procedures or Deliveries: Results From 5 Prospective Multicenter Studies

Annie Borel-Derlon, MD, PhD, Augusto B. Federici, MD, Jenny Goudemand, MD, PhD, Catherine Chatelanaz, Celine Henriet, Françoise Bridey
Journal: Blood
Blood (2011) 118 (21): 383.
https://doi.org/10.1182/blood.V118.21.383.383
Published: 2011
Journal Articles

French Multicenter Study for Post-Marketing Survey of WILFACTIN®: A Von Willebrand Factor Concentrate with a Low FVIII Content.

Annie Borel-Derlon, Jenny Goudemand, Chantal Rothschild, Catherine Chatelanaz, Françoise Bridey, French Post-Marketing Study Group5
Journal: Blood
Blood (2006) 108 (11): 4052.
https://doi.org/10.1182/blood.V108.11.4052.4052
Published: 2006